No Data
No Data
XORTX Therapeutics | 6-K: Report of foreign private issuer (related to financial reporting)
Stocks in Play: XORTX Therapeutics Inc.
XORTX Therapeutics Adjusts Warrant Terms
XORTX Therapeutics Brief: Says Repriced Balance of Warrants Issued in Connection With October 2021 US IPO
07:01 AM EDT, 05/17/2024 (MT Newswires) -- XORTX Therapeutics Brief: Says Repriced Balance of Warrants Issued in Connection with October 2021 US IPO
XORTX Reprices Balance of Warrants Issued in Connection With October 2021 US IPO
CALGARY, Alberta, May 17, 2024 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the "Company") (NASDAQ:XRTX, TSXV:XRTX, Frankfurt: ANU)), a late stage clinical pharmaceutical company focused on developing
Xortx Therapeutics Q1 Financial Snapshot
No Data